| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-47515-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-44075 | |||
| BSA Free | NBP2-52975-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-38691-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-90128-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-37871-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-48854-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-79843 | |||
![Western Blot: Vitronectin Antibody [NBP2-20866] - Proteomics analysis of losartan-mediated reversion of early fibrotic RDEB changes.Bar graph show abundance of representative proteins normalized by losartan treatment. Mean +/- S.E.M. (LFQ intensity) of groups of individual mice (wild-type, untreated, & losartan-treated C7-hypomorphic mice). Unpaired t-test calculated significance. Abundance of Lrg1: *P-value C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.022; abundance of serpin f2: **P-value untreated C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.0084; abundance of vitronectin: **P-value untreated C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.0094. Western blots of skin lysates from wild-type, untreated C7-hypomorphic, & 7-week losartan-treated C7-hypomorphic mice not used for proteomics. Image collected & cropped by CiteAb from the following publication (www.onlinelibrary.wiley.com/doi/10.15252/emmm.201505061) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-Western-Blot-NBP2-20866-img0009.jpg "<b>Biological Strategies Validation. </b>Western Blot: Vitronectin Antibody [NBP2-20866] - Proteomics analysis of losartan-mediated reversion of early fibrotic RDEB changes.Bar graph show abundance of representative proteins normalized by losartan treatment. Mean +/- S.E.M. (LFQ intensity) of groups of individual mice (wild-type, untreated, & losartan-treated C7-hypomorphic mice). Unpaired t-test calculated significance. Abundance of Lrg1: *P-value C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.022; abundance of serpin f2: **P-value untreated C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.0084; abundance of vitronectin: **P-value untreated C7-hypomorphic vs. losartan-treated C7-hypomorphic mice = 0.0094. Western blots of skin lysates from wild-type, untreated C7-hypomorphic, & 7-week losartan-treated C7-hypomorphic mice not used for proteomics. Image collected & cropped by CiteAb from the following publication (www.onlinelibrary.wiley.com/doi/10.15252/emmm.201505061) licensed under a CC-BY license.")
![<b>Biological Strategies Validation. </b>Immunohistochemistry-Paraffin: Vitronectin Antibody [NBP2-20866] - Vitronectin antibody detects Vitronectin protein by immunohistochemical analysis. Sample: Paraffin-embedded human lung cancer. Vitronectin stained by Vitronectin antibody diluted at 1:1000.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-Immunohistochemistry-Paraffin-NBP2-20866-img0008.jpg)
![Immunohistochemistry-Paraffin: Vitronectin Antibody [NBP2-20866] - Human colon carcinoma, using Vitronectin antibody at 1:500 dilution. Antigen Retrieval: Trilogy™ (EDTA based, pH 8.0) buffer, 15min.](http://images.novusbio.com/fullsize/Vitronectin-Antibody-Immunohistochemistry-Paraffin-NBP2-20866-img0003.jpg)
![Western Blot: Vitronectin Antibody [NBP2-20866] - HepG2 whole cell extract and conditioned medium (30 ug) were separated by 10% SDS-PAGE, and the membrane was blotted with Vitronectin antibody (NBP2-20866) diluted at 1:1000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/nbp2-20866_rabbit-polyclonal-vitronectin-antibody-910202420104489.jpg)
![Immunohistochemistry-Paraffin: CD98 Antibody [NBP2-47515] - Analysis in human kidney and skeletal muscle tissues using NBP2-47515 antibody. Corresponding SLC3A2 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/CD98-Antibody-Immunohistochemistry-Paraffin-NBP2-47515-img0013.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CD98 Antibody [NBP2-47515] - Analysis in human kidney and skeletal muscle tissues using NBP2-47515 antibody. Corresponding SLC3A2 RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Western Blot: CD98 Antibody [NBP2-47515] - Analysis in human cell lines SK-MEL-30 and HEK293 using anti-SLC3A2 antibody. Corresponding SLC3A2 RNA-seq data are presented for the same cell lines. Loading control: anti-PFN1.](http://images.novusbio.com/fullsize/CD98-Antibody-Western-Blot-NBP2-47515-img0012.jpg)
![Immunocytochemistry/Immunofluorescence: CD98 Antibody [NBP2-47515] - Staining of human cell line U-2 OS shows localization to nucleus, plasma membrane and cytosol.](http://images.novusbio.com/fullsize/CD98-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-47515-img0010.jpg)
![Immunohistochemistry-Paraffin: CD98 Antibody [NBP2-47515] - Staining of human skeletal muscle shows no positivity in myocytes as expected.](http://images.novusbio.com/fullsize/CD98-Antibody-Immunohistochemistry-Paraffin-NBP2-47515-img0017.jpg)
![Immunohistochemistry-Paraffin: CD98 Antibody [NBP2-47515] - Staining of human kidney shows strong membranous positivity in cells in tubules.](http://images.novusbio.com/fullsize/CD98-Antibody-Immunohistochemistry-Paraffin-NBP2-47515-img0014.jpg)
![Immunohistochemistry-Paraffin: CD98 Antibody [NBP2-47515] - Staining of human testis shows moderate membranous positivity in cells in seminiferous ducts.](http://images.novusbio.com/fullsize/CD98-Antibody-Immunohistochemistry-Paraffin-NBP2-47515-img0015.jpg)
![Immunohistochemistry-Paraffin: CD98 Antibody [NBP2-47515] - Staining of human placenta shows moderate membranous positivity in trophoblastic cells.](http://images.novusbio.com/fullsize/CD98-Antibody-Immunohistochemistry-Paraffin-NBP2-47515-img0016.jpg)
![Western Blot: CD117/c-kit Antibody (CL1657) [NBP2-52975] - Lane 1: Marker [kDa], Lane 2: Human cell line RT-4](http://images.novusbio.com/fullsize/CD117-c-kit-Antibody-CL1657-Western-Blot-NBP2-52975-img0006.jpg "Western Blot: CD117/c-kit Antibody (CL1657) [NBP2-52975] - Lane 1: Marker [kDa], Lane 2: Human cell line RT-4")
![Immunohistochemistry-Paraffin: CD117/c-kit Antibody (CL1657) [NBP2-52975] - Staining of human stomach shows strong positivity in a subset of lymphoid cells.](http://images.novusbio.com/fullsize/CD117-c-kit-Antibody-CL1657-Immunohistochemistry-Paraffin-NBP2-52975-img0005.jpg)
![Immunohistochemistry-Paraffin: CD117/c-kit Antibody (CL1657) [NBP2-52975] - Staining of human cerebellum shows moderate positivity in neuropil of the molecular layer.](http://images.novusbio.com/fullsize/CD117-c-kit-Antibody-CL1657-Immunohistochemistry-Paraffin-NBP2-52975-img0001.jpg)
![Immunohistochemistry-Paraffin: CD117/c-kit Antibody (CL1657) [NBP2-52975] - Staining of human colon shows strong immunoreactivity in a subset of lymphoid cells.](http://images.novusbio.com/fullsize/CD117-c-kit-Antibody-CL1657-Immunohistochemistry-Paraffin-NBP2-52975-img0002.jpg)
![Immunohistochemistry-Paraffin: CD117/c-kit Antibody (CL1657) [NBP2-52975] - Staining of human pancreas shows absence of immunoreactivity (negative control).](http://images.novusbio.com/fullsize/CD117-c-kit-Antibody-CL1657-Immunohistochemistry-Paraffin-NBP2-52975-img0003.jpg)
![Immunohistochemistry-Paraffin: CD117/c-kit Antibody (CL1657) [NBP2-52975] - Staining of human small intestine shows strong immunoreactivity in a subset of lymphoid cells (macrophages).](http://images.novusbio.com/fullsize/CD117-c-kit-Antibody-CL1657-Immunohistochemistry-Paraffin-NBP2-52975-img0004.jpg)
![Immunohistochemistry-Paraffin: HLA DRA Antibody [NBP2-38691] - Staining in human lymph node and skeletal muscle tissues . Corresponding HLA-DRA RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/HLA-DRA-Antibody-Immunohistochemistry-Paraffin-NBP2-38691-img0006.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: HLA DRA Antibody [NBP2-38691] - Staining in human lymph node and skeletal muscle tissues . Corresponding HLA-DRA RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: HLA DRA Antibody [NBP2-38691] - Staining of human liver shows positivity in Kupffer cells.](http://images.novusbio.com/fullsize/HLA-DRA-Antibody-Immunohistochemistry-Paraffin-NBP2-38691-img0002.jpg)
![Immunohistochemistry-Paraffin: HLA DRA Antibody [NBP2-38691] - Staining of human lymph node shows membranous positivity in lymphoid cells.](http://images.novusbio.com/fullsize/HLA-DRA-Antibody-Immunohistochemistry-Paraffin-NBP2-38691-img0003.jpg)
![Immunohistochemistry-Paraffin: HLA DRA Antibody [NBP2-38691] - Staining of human skeletal muscle shows no positivity in myocytes.](http://images.novusbio.com/fullsize/HLA-DRA-Antibody-Immunohistochemistry-Paraffin-NBP2-38691-img0004.jpg)
![Immunohistochemistry-Paraffin: HLA DRA Antibody [NBP2-38691] - Staining of human small intestine shows positivity in lymphoid cells.](http://images.novusbio.com/fullsize/HLA-DRA-Antibody-Immunohistochemistry-Paraffin-NBP2-38691-img0005.jpg)
![<b>Independent Antibodies Validation. </b>Immunohistochemistry-Paraffin: HLA DRA Antibody [NBP2-38691] - Staining of human cerebral cortex, colon, kidney and lymph node using Anti-HLA-DRA antibody (A) shows similar protein distribution across tissues to independent antibody (B).](http://images.novusbio.com/fullsize/HLA-DRA-Antibody-Immunohistochemistry-Paraffin-NBP2-38691-img0008.jpg)
![Immunohistochemistry-Paraffin: HLA DRA Antibody [NBP2-38691] - Staining of human colon using Anti-HLA-DRA antibody.](http://images.novusbio.com/fullsize/HLA-DRA-Antibody-Immunohistochemistry-Paraffin-NBP2-38691-img0009.jpg)
![Immunohistochemistry-Paraffin: HLA DRA Antibody [NBP2-38691] - Staining of human cerebral cortex using Anti-HLA-DRA antibody.](http://images.novusbio.com/fullsize/HLA-DRA-Antibody-Immunohistochemistry-Paraffin-NBP2-38691-img0010.jpg)
![Immunohistochemistry-Paraffin: HLA DRA Antibody [NBP2-38691] - Staining of human kidney using Anti-HLA-DRA antibody.](http://images.novusbio.com/fullsize/HLA-DRA-Antibody-Immunohistochemistry-Paraffin-NBP2-38691-img0011.jpg)
![Immunocytochemistry/Immunofluorescence: Syntenin 1 Antibody [NBP1-86979] - Immunofluorescent staining of human cell line A-431 shows localization to nucleoplasm, nuclear membrane & cytosol.](http://images.novusbio.com/fullsize/Syntenin-1-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-86979-img0005.jpg "Immunocytochemistry/Immunofluorescence: Syntenin 1 Antibody [NBP1-86979] - Immunofluorescent staining of human cell line A-431 shows localization to nucleoplasm, nuclear membrane & cytosol.")
![Immunohistochemistry-Paraffin: Syntenin 1 Antibody [NBP1-86979] - Staining of human duodenum shows moderate cytoplasmic positivity in glandular cells.](http://images.novusbio.com/fullsize/Syntenin-1-Antibody-Immunohistochemistry-Paraffin-NBP1-86979-img0014.jpg)
![Immunohistochemistry-Paraffin: Syntenin 1 Antibody [NBP1-86979] - Staining of human lymph node shows strong cytoplasmic positivity in germinal center cells.](http://images.novusbio.com/fullsize/Syntenin-1-Antibody-Immunohistochemistry-Paraffin-NBP1-86979-img0009.jpg)
![Immunohistochemistry-Paraffin: Syntenin 1 Antibody [NBP1-86979] - Staining of human liver shows strong cytoplasmic positivity in hepatocytes.](http://images.novusbio.com/fullsize/Syntenin-1-Antibody-Immunohistochemistry-Paraffin-NBP1-86979-img0012.jpg)
![Immunohistochemistry-Paraffin: Syntenin 1 Antibody [NBP1-86979] - Staining of human placenta shows weak tcytoplasmic positivity in trophoblastic cells.](http://images.novusbio.com/fullsize/Syntenin-1-Antibody-Immunohistochemistry-Paraffin-NBP1-86979-img0013.jpg)
![Western Blot: MCPIP1/ZC3H12A Antibody [NBP2-37871] - Analysis in control (vector only transfected HEK293T lysate) and ZC3H12A over-expression lysate (Co-expressed with a C-terminal myc-DDK tag (3.1 kDa) in mammalian HEK293T cells).](http://images.novusbio.com/fullsize/MCPIP1-ZC3H12A-Antibody-Western-Blot-NBP2-37871-img0004.jpg "Western Blot: MCPIP1/ZC3H12A Antibody [NBP2-37871] - Analysis in control (vector only transfected HEK293T lysate) and ZC3H12A over-expression lysate (Co-expressed with a C-terminal myc-DDK tag (3.1 kDa) in mammalian HEK293T cells).")
![Immunocytochemistry/Immunofluorescence: MCPIP1/ZC3H12A Antibody [NBP2-37871] - Staining of human cell line U-251 MG shows localization to cytoplasmic bodies. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/MCPIP1-ZC3H12A-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-37871-img0002.jpg)
![Immunohistochemistry-Paraffin: MCPIP1/ZC3H12A Antibody [NBP2-37871] - Staining of human skeletal muscle shows no positivity in myocytes as expected.](http://images.novusbio.com/fullsize/MCPIP1-ZC3H12A-Antibody-Immunohistochemistry-Paraffin-NBP2-37871-img0008.jpg)
![Immunohistochemistry-Paraffin: MCPIP1/ZC3H12A Antibody [NBP2-37871] - Staining of human tonsil shows strong membranous positivity in non-germinal center cells.](http://images.novusbio.com/fullsize/MCPIP1-ZC3H12A-Antibody-Immunohistochemistry-Paraffin-NBP2-37871-img0005.jpg)
![Immunohistochemistry-Paraffin: MCPIP1/ZC3H12A Antibody [NBP2-37871] - Staining of human colon shows moderate cytoplasmic positivity in lymphoid cells.](http://images.novusbio.com/fullsize/MCPIP1-ZC3H12A-Antibody-Immunohistochemistry-Paraffin-NBP2-37871-img0006.jpg)
![Immunohistochemistry-Paraffin: MCPIP1/ZC3H12A Antibody [NBP2-37871] - Staining of human testis shows moderate cytoplasmic and nuclear positivity in Leydig cells.](http://images.novusbio.com/fullsize/MCPIP1-ZC3H12A-Antibody-Immunohistochemistry-Paraffin-NBP2-37871-img0007.jpg)
![Immunohistochemistry-Paraffin: Calreticulin Antibody [NBP2-48491] - Staining in human thyroid gland and pancreas tissues using anti-CALR antibody. Corresponding CALR RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/Calreticulin-Antibody-Immunohistochemistry-Paraffin-NBP2-48491-img0007.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: Calreticulin Antibody [NBP2-48491] - Staining in human thyroid gland and pancreas tissues using anti-CALR antibody. Corresponding CALR RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Western Blot: Calreticulin Antibody [NBP2-48491] - Analysis in mouse cell line NIH-3T3 and rat cell line NBT-II.](http://images.novusbio.com/fullsize/Calreticulin-Antibody-Western-Blot-NBP2-48491-img0005.jpg)
![Immunohistochemistry-Paraffin: Calreticulin Antibody [NBP2-48491] - Staining of human pancreas shows low expression as expected.](http://images.novusbio.com/fullsize/Calreticulin-Antibody-Immunohistochemistry-Paraffin-NBP2-48491-img0006.jpg)
![Western Blot: Calreticulin Antibody [NBP2-48491] - Analysis in human cell line HL-60.](http://images.novusbio.com/fullsize/Calreticulin-Antibody-Western-Blot-NBP2-48491-img0004.jpg)
![Immunohistochemistry-Paraffin: Calreticulin Antibody [NBP2-48491] - Staining of human thyroid gland shows strong cytoplasmic positivity.](http://images.novusbio.com/fullsize/Calreticulin-Antibody-Immunohistochemistry-NBP2-48491-img0001.jpg)
![Lane 1: Marker [kDa] 250, 130, 100, 70, 55, 35, 25, 15, 10Lane 2: Mouse Cerebral Cortex tissue](http://images.novusbio.com/fullsize/nbp3-52088_mouse-mbp-mab-cl2829-western-blot-273202615204516.jpg)
![Lane 1: Marker [kDa] 250, 130, 100, 70, 55, 35, 25, 15, 10Lane 2: Human Cerebral Cortex tissue](http://images.novusbio.com/fullsize/nbp3-52088_mouse-mbp-mab-cl2829-western-blot-27320261527554.jpg)
![Immunohistochemistry-Paraffin: Carboxylesterase 1/CES1 Antibody [NBP2-48854] - Analysis in human liver and cerebral cortex tissues using NBP2-48854 antibody. Corresponding CES1 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/Carboxylesterase-1-CES1-Antibody-Immunohistochemistry-Paraffin-NBP2-48854-img0012.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: Carboxylesterase 1/CES1 Antibody [NBP2-48854] - Analysis in human liver and cerebral cortex tissues using NBP2-48854 antibody. Corresponding CES1 RNA-seq data are presented for the same tissues.")
![<b>Independent Antibodies Validation and Orthogonal Strategies Validation.</b>Immunohistochemistry-Paraffin: Carboxylesterase 1/CES1 Antibody [NBP2-48854] - Staining of human cerebral cortex, liver, prostate and upper gastrointestinal using Anti-CES1 antibody NBP2-48854 (A) shows similar protein distribution across tissues to independent antibody NBP1-85691 (B).](http://images.novusbio.com/fullsize/Carboxylesterase-1-CES1-Antibody-Immunohistochemistry-Paraffin-NBP2-48854-img0014.jpg)
![Immunocytochemistry/Immunofluorescence: Carboxylesterase 1/CES1 Antibody [NBP2-48854] - Analysis of human cell line Hep G2 shows positivity in endoplasmic reticulum. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/Carboxylesterase-1-CES1-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-48854-img0001.jpg)
![Immunohistochemistry-Paraffin: Carboxylesterase 1/CES1 Antibody [NBP2-48854] - Staining of human prostate shows moderate cytoplasmic positivity in smooth muscle cells.](http://images.novusbio.com/fullsize/Carboxylesterase-1-CES1-Antibody-Immunohistochemistry-Paraffin-NBP2-48854-img0017.jpg)
![Immunohistochemistry-Paraffin: Carboxylesterase 1/CES1 Antibody [NBP2-48854] - Staining of human cerebral cortex shows no cytoplasmic positivity in neuronal cells as expected.](http://images.novusbio.com/fullsize/Carboxylesterase-1-CES1-Antibody-Immunohistochemistry-Paraffin-NBP2-48854-img0013.jpg)
![Immunohistochemistry-Paraffin: Carboxylesterase 1/CES1 Antibody [NBP2-48854] - Staining of human liver shows strong cytoplasmic positivity in hepatocytes.](http://images.novusbio.com/fullsize/Carboxylesterase-1-CES1-Antibody-Immunohistochemistry-Paraffin-NBP2-48854-img0015.jpg)
![Immunohistochemistry-Paraffin: Carboxylesterase 1/CES1 Antibody [NBP2-48854] - Staining of human lung shows strong cytoplasmic positivity in macrophages.](http://images.novusbio.com/fullsize/Carboxylesterase-1-CES1-Antibody-Immunohistochemistry-Paraffin-NBP2-48854-img0016.jpg)
![Immunohistochemistry-Paraffin: Carboxylesterase 1/CES1 Antibody [NBP2-48854] - Staining of human small intestine shows strong cytoplasmic positivity in enteroendocrine cells.](http://images.novusbio.com/fullsize/Carboxylesterase-1-CES1-Antibody-Immunohistochemistry-Paraffin-NBP2-48854-img0018.jpg)
![Western Blot: HLA DQ/DR/DP Antibody (HLA-Pan/2967R) [NBP2-79709] - Western Blot Analysis of Ramos cell lysate using HLA DQ/DR/DP Antibody (HLA-Pan/2967R).](http://images.novusbio.com/fullsize/HLA-DQ-DR-DP-Antibody-HLA-Pan-2967R-Western-Blot-NBP2-79709-img0005.jpg "Western Blot: HLA DQ/DR/DP Antibody (HLA-Pan/2967R) [NBP2-79709] - Western Blot Analysis of Ramos cell lysate using HLA DQ/DR/DP Antibody (HLA-Pan/2967R).")
![Immunocytochemistry/Immunofluorescence: HLA DQ/DR/DP Antibody (HLA-Pan/2967R) [NBP2-79709] - Immunofluorescence staining of PFA-fixed Ramos cells. HLA DQ/DR/DP Recombinant Rabbit Monoclonal Antibody (HLA DQ/DR/DP/2967R) followed by goat anti-rabbit IgG-CF488 (green). Nuclei stained with RedDot.](http://images.novusbio.com/fullsize/HLA-DQ-DR-DP-Antibody-HLA-Pan-2967R-Immunocytochemistry-Immunofluorescence-NBP2-79709-img0006.jpg)
![Immunohistochemistry-Paraffin: HLA DQ/DR/DP Antibody (HLA-Pan/2967R) [NBP2-79709] - Formalin-fixed, paraffin-embedded human Tonsil stained with HLA DQ/DR/DP Antibody (HLA-Pan/2967R).](http://images.novusbio.com/fullsize/HLA-DQ-DR-DP-Antibody-HLA-Pan-2967R-Immunohistochemistry-Paraffin-NBP2-79709-img0003.jpg)
![Flow Cytometry: HLA DQ/DR/DP Antibody (HLA-Pan/2967R) [NBP2-79709] - Flow Cytometric Analysis of Raji cells using HLA DQ/DR/DP Antibody (HLA-Pan/2967R)followed by goat anti-rabbit IgG-CF488 (Blue); Isotype control (Red).](http://images.novusbio.com/fullsize/HLA-DQ-DR-DP-Antibody-HLA-Pan-2967R-Flow-Cytometry-NBP2-79709-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: HLA DQ/DR/DP Antibody (HLA-Pan/2967R) [NBP2-79709] - Immunofluorescence staining of Raji cells using HLA DQ/DR/DP Antibody (HLA-Pan/2967R) followed by goat anti-rabbit IgG-CF488 (Green). Nuclei stained with RedDot (Red).](http://images.novusbio.com/fullsize/HLA-DQ-DR-DP-Antibody-HLA-Pan-2967R-Immunocytochemistry-Immunofluorescence-NBP2-79709-img0002.jpg)
![Protein Array: HLA DQ/DR/DP Antibody (HLA-Pan/2967R) [NBP2-79709] - Analysis of Protein Array containing more than 19,000 full-length human proteins using HLA DQ/DR/DP Antibody (HLA-Pan/2967R). Z- and S- Score: The Z-score represents the strength of a signal that a monoclonal antibody (MAb) (in combination with a fluorescently-tagged anti-IgG secondary antibody) produces when binding to a particular protein on the HuProt(TM) array. Z-scores are described in units of standard deviations (SD's) above the mean value of all signals generated on that array. If targets on HuProt(TM) are arranged in descending order of the Z-score, the S-score is the difference (also in units of SD's) between the Z-score. S-score therefore represents the relative target specificity of a MAb to its intended target. A MAb is considered to specific to its intended target, if the MAb has an S-score of at least 2.5.](http://images.novusbio.com/fullsize/HLA-DQ-DR-DP-Antibody-HLA-Pan-2967R-Protein-Array-NBP2-79709-img0004.jpg)
![Functional (Inhibition): TIRAP (TLR2 and TLR4) Inhibitor Peptide Set [NBP2-29331] - TLR2/NF-kB/SEAPorter HEK 293 (NBP2-26274) cells were plated in 96-well plates at 5 x 10^4 cells/well for 16 h. Cells were preincubated with different concentrations (0, 1, 5, 10, 25 and 50 uM) of Inhibitory Peptide (NBP2-29331) and Control Peptide (NBP2-29334) for 1 h. Cells were then stimulated with 1 ng/ml Pam3CSK4 (NBP2-25297) for 24 h. Secreted alkaline phosphatase (SEAP) was analyzed using SEAPorter Assay Kit (NBP2-25285). *p < 0.05 versus control peptide at the corresponding concentrations (Mann-Whitney U test).](http://images.novusbio.com/fullsize/TIRAP-TLR2-and-TLR4-Inhibitor-Peptide-Set-Functional-Inhibition-NBP2-29331-img0001.jpg "Functional (Inhibition): TIRAP (TLR2 and TLR4) Inhibitor Peptide Set [NBP2-29331] - TLR2/NF-kB/SEAPorter HEK 293 (NBP2-26274) cells were plated in 96-well plates at 5 x 10^4 cells/well for 16 h. Cells were preincubated with different concentrations (0, 1, 5, 10, 25 and 50 uM) of Inhibitory Peptide (NBP2-29331) and Control Peptide (NBP2-29334) for 1 h. Cells were then stimulated with 1 ng/ml Pam3CSK4 (NBP2-25297) for 24 h. Secreted alkaline phosphatase (SEAP) was analyzed using SEAPorter Assay Kit (NBP2-25285). *p < 0.05 versus control peptide at the corresponding concentrations (Mann-Whitney U test).")